【摘 要】
：
Background and Aims: The therapeutic effect of teno-fovir alafenamide fumarate (TAF), tenofovir disoproxil fu-marate (TDF) and entecavir (ETV) on chronic hepati
【机 构】
：
Department of Infectious Disease,Qingdao Municipal Hospital,Qingdao University,Qingdao,Shandong,Chin
论文部分内容阅读
Background and Aims: The therapeutic effect of teno-fovir alafenamide fumarate (TAF), tenofovir disoproxil fu-marate (TDF) and entecavir (ETV) on chronic hepatitis B (CHB) patients remains inconsistent. The aim of this study was to explore the differences in virological responses to TAF, TDF and ETV in patients with CHB. Methods: Litera-ture searches were conducted of the PubMed, EMBASE, and the Cochrane Library databases to identify randomized con-trolled trials and observational studies published up to July 21, 2020. Statistical comparisons of virological response between TDF, ETV, and TAF were carried out with pooled odds ratio (OR) values. Results: The virological response in TDF-treated CHB patients was notably superior to that of the ETV-treated CHB patients after 12-weeks [OR=1.12, 95％ confidence interval (CI): 0.89–1.41], 24-weeks (OR=1.33, 95％ CI: 1.11–1.61), 48-weeks (OR=1.62, 95％ CI: 1.16–2.25), 72-weeks (OR=1.43, 95％ CI: 0.78–2.62), and 96-weeks (OR=1.56, 95％ CI: 0.87–2.81) treatment. No significant difference was observed for the virological re-sponses in CHB patients after 48-weeks treatment with TAF or TDF. The virological response in TDF+ETV-treated CHB patients was superior to that of TDF-treated CHB patients after 24-weeks, 48-weeks (OR=1.54, 95％ CI: 1.17–2.02), 96-weeks, and 144-weeks. Conclusions: The virological response in TDF-treated CHB patients was superior to that in ETV-treated CHB patients, but there was no significant difference between TAF and TDF. In addition, the therapeu-tic effect of TDF+ETV was superior to TDF alone.
其他文献
Background and Aims: Coronavirus disease 2019 (COV-ID-19) is a global threat, affecting more than 100 million people and causing over 2 million deaths. Liver la
B cell-mediated humoral immunity plays a vital role in viral infections, including chronic hepatitis B virus (HBV) infection, which remains a critical global pu
目前肺癌是世界上发生率最高的癌症,因为其早期诊断率低,复发风险高,对治疗药物的耐药性,使得肺癌患者预后仍不理想,所以急需新的方法对肺癌进行早期诊断,实时监测和有效治疗
Background and Aims: Ras-related nuclear (RAN) protein is a small GTP-binding protein that is indispensable for the translocation of RNA and proteins through th
Background and Aims: Post-hepatectomy liver failure (PHLF) is a severe complication and main cause of death in patients undergoing hepatectomy. The aim of this
Background and Aims: AT-rich interactive domain-con-taining protein 1A (ARID1A) is frequently mutated or defi-cient in hepatocellular carcinoma (HCC). However,
Background and Aims: Metabolic-associated fatty liver disease (MAFLD) is driven by high caloric intake and sed-entary lifestyle. Migration towards high income c
目的探讨组织多普勒成像(TDI)中二尖瓣舒张早期峰速(E)/二尖瓣瓣环舒张早期峰速(Em′)、E/[Em′×二尖瓣瓣环收缩期峰速(Sm′)]对冠状动脉搭桥术(CABG)后心力衰竭的评估价值。方法回顾性分析北部战区总医院2020年1月1日—10月1日收治的非体外循环下行CABG的470例患者的临床资料。根据术后第2天的脑钠肽平均值,将患者分入心力衰竭组(脑钠肽>1000 ng/L,n=169)和非心力衰竭组(脑钠肽≤1000 ng/L,n=301)。超声心动图二维常规模式下测量左房前后径(LAD)、左
Background and Aims: Previous studies reported that serum resistin levels were remarkably changed in patients with nonalcoholic fatty liver disease (NAFLD) but
急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL)是常见的造血系统恶性肿瘤,其发生于老年患者可因老年人群机体功能减退等导致治疗更为困难,预后更差,且一旦复发或难治(R/R),常规化疗再缓解率极低。本例老年B细胞-ALL(B-ALL)患者原发耐药,CD19嵌合抗原受体T细胞(CAR-T)免疫治疗后采用来那度胺联合白介素-2(IL-2)维持治疗,目前已持续微小残留病(MRD)阴性完全缓解(CR)超过45个月。现报告如下。